McNulty, Joseph
(2023)
The Impact of CD40L on Mature Dendritic Cell and Their EV Production.
Master's Thesis, University of Pittsburgh.
(Unpublished)
Abstract
As HIV becomes a more chronic and manageable condition, the research of the disease has shifted. ART has played a large role in raising the life expectancy of people living with HIV. However, it has some drawbacks and has created a landscape for the need of a novel and more effective therapeutic to eradicate HIV. The dendritic cell (DC) shows promise as a role player in this novel therapeutic due to its ability to link both the innate and adaptive arm of the immune systems. Several studies have shown that type-1 polarized DCs (DC1s) are more effective at driving latency reversal and CTL responses, when stimulated with CD40L, a costimulatory molecule derived from CD4+ T helper cells that has many immunologic functions. A clinically relevant type-1 polarized DC vaccine platform called the alpha-DC1 (αDC1) developed at the University of Pittsburgh is currently being studied as an alternative to more commonly used DC-based vaccines, sometimes referred to as DC2. To accurately compare the two DC subsets and to gain a better understanding of each cell type and their interaction with other immune cells, we performed tests to detail the characterization of these DC-based vaccine platforms and their responsiveness to the T helper cell signal CD40L. We assess their differences through characterization of their phenotype, morphology, cytokine production, single cell transcriptomics, and extracellular vesicle production. It is understood that the knowledge obtained from this study would give researchers an in-depth understanding of these clinically relevant DC subsets so that they may be used more effectively as an HIV therapeutic.
Share
| Citation/Export: |
|
| Social Networking: |
|
Details
| Item Type: |
University of Pittsburgh ETD
|
| Status: |
Unpublished |
| Creators/Authors: |
|
| ETD Committee: |
|
| Date: |
17 May 2023 |
| Date Type: |
Publication |
| Defense Date: |
20 April 2023 |
| Approval Date: |
17 May 2023 |
| Submission Date: |
29 April 2023 |
| Access Restriction: |
No restriction; Release the ETD for access worldwide immediately. |
| Number of Pages: |
67 |
| Institution: |
University of Pittsburgh |
| Schools and Programs: |
School of Public Health > Infectious Diseases and Microbiology |
| Degree: |
MS - Master of Science |
| Thesis Type: |
Master's Thesis |
| Refereed: |
Yes |
| Uncontrolled Keywords: |
N/A |
| Date Deposited: |
17 May 2023 16:53 |
| Last Modified: |
17 May 2023 16:53 |
| URI: |
http://d-scholarship.pitt.edu/id/eprint/44822 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |
![[feed]](/images/feed-icon-32x32.png){kind=icon}